Pharmacogenomics in 2023: Big Studies, Big Results, Big Implications, Big Responsibilities
-
Chair(s):
Andrew Somogyi,
Professor in Clinical and Experimental Pharmacology,University of Adelaide, Adelaide, AustraliaAnn Daly,
Professor of Pharmacogenomics,Newcastle University, Newcastle, United Kingdom -
Session description:
From Bioinformatics to Machine Learning in Pharmacogenomics to enhance drug effectiveness and safety
Professor Russ Altman
Professor of Bioengineering, Genetics, & Medicine, Stanford University, Stanford, The United States of AmericaWhat have we learnt and what will we learn from the UBIQUITIOUS Pharmacogenomics Consortium
Dr Erika Cecchin
Experimental and Clinical Pharmacology Unit, National Cancer Institute, Aviano, ItalyOral communication speaker - to be confirmed in 2022.
Predicting and improving response to medicines: lessons learnt from genomes and electronic health records at VUMC
Professor Sara van Driest
Vanderbilt University, Nashville, The United States of AmericaMachine learning to better understand and predict drug safety
Professor Masaru Koido
Yokohama City University, Japan -
Sponsored by:
Speakers
-
Dr Erika CecchinDirigente farmacista, National Cancer Institute, Aviano, Italy
-
Professor Masaru KoidoYokohama City University, Yokohama, Japan
-
Professor Russ AltmanProfessor of Bioengineering, Genetics, & Medicine, Stanford University, Stanford, The United States of America
-
Professor Sara van DriestVanderbilt University, Nashville, The United States of America
Leave A Comment